BioLabShare, LLC plans to build a bioreseasrch wet lab and a residential complex on several acres it will lease from Dormerville Properties, LLC in Huntsville, Alabama. BioLabShare, LLC focuses on creating a co-working and co-living space for bioentrepreneurs. The company plans to partner with Alabama A&M University and Oakwood University to promote bioresearch with those HBCU institutions.
CD BioSciences introduces comprehensive solutions for GPCR expression based on various strategies and technique platforms to facilitate customers’ cutting-edge programs.
BOC Sciences has prepared a long list of first-rate pseudoUridines to be presented at two industry-renowned exhibitions—CPhI North America and TIDES USA 2022.
Pharmaceutical 2022 aims to join new ideas and technologies under the field of development design and drug taxation industry and student research to share recent innovation and applications and sharing interactive arguments increase.
The meeting has space to submit services, products, innovations and research results to companies and agencies.
Alfa Chemistry aims to solve the toughest filtration, purification and separation challenges by introducing a comprehensive range of basic filtration products.
Known as a third-party testing laboratory, Alfa Chemistry Testing Lab recently announces to further expand its specialized testing range to cooking oil products, including animal-derived oils and different types of vegetable oils.
Earlier this month, CD Formulation announces that it is now capable of providing nitrosamine impurities analysis service for customers who are involved with drug formulation projects and need help from CRO companies like CD Formulation.
CD Formulation announces the launch of tailored solutions for increased bioavailability excipients, which aims to tackle the issue of poor bioavailability, a long-lasting challenge in drug development.
Alfa Chemistry launches an integrated platform with small molecule APIs/intermediates development and manufacturing capabilities from preclinical to commercial stages.
Alfa Chemistry recently introduces environmental standards, which is a step to further diversify its offering of chromatography standards and also in response to the increasing needs for environmental analysis.
Focused Energy appoints former director of Lawrence Livermore National Laboratory (LLNL) as external board member of Focused Energy Inc. Focused Energy aims to use inertial fusion to enable large-scale production of climate-friendly energy
Prof. Jens Schwamborn co-founded the spin-off project "OrganoTherapeutics" in 2019, which uses 3D brain organoids to research active substances for the treatment of Parkinson's disease.